115 related articles for article (PubMed ID: 29541237)
1. Celecoxib enhances sensitivity to chemotherapy drugs of T-cell lymphoma.
Ma M; Yang X; Zhao L; Wang X; Liu L; Jiao W; Wei Y; Shan B
Oncol Lett; 2018 Apr; 15(4):4649-4656. PubMed ID: 29541237
[TBL] [Abstract][Full Text] [Related]
2. Mda-7/IL-24 enhances sensitivity of B cell lymphoma to chemotherapy drugs.
Ma M; Zhao L; Sun G; Zhang C; Liu L; Du Y; Yang X; Shan B
Oncol Rep; 2016 May; 35(5):3122-30. PubMed ID: 26883473
[TBL] [Abstract][Full Text] [Related]
3. Reversal of multidrug resistance in drug-resistant human gastric cancer cell line SGC7901/VCR by antiprogestin drug mifepristone.
Li DQ; Wang ZB; Bai J; Zhao J; Wang Y; Hu K; Du YH
World J Gastroenterol; 2004 Jun; 10(12):1722-5. PubMed ID: 15188493
[TBL] [Abstract][Full Text] [Related]
4. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
[TBL] [Abstract][Full Text] [Related]
5. Effects of celecoxib on the reversal of multidrug resistance in human gastric carcinoma by downregulation of the expression and activity of P-glycoprotein.
Huang L; Wang C; Zheng W; Liu R; Yang J; Tang C
Anticancer Drugs; 2007 Oct; 18(9):1075-80. PubMed ID: 17704658
[TBL] [Abstract][Full Text] [Related]
6. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
[TBL] [Abstract][Full Text] [Related]
7. [Celecoxib enhances the chemotherapy sensitivity of KB/VCR cell lines to vincristine].
Yan Y; Li W
Hua Xi Kou Qiang Yi Xue Za Zhi; 2013 Aug; 31(4):403-7. PubMed ID: 23991582
[TBL] [Abstract][Full Text] [Related]
8. Formononetin potentiates epirubicin-induced apoptosis via ROS production in HeLa cells in vitro.
Lo YL; Wang W
Chem Biol Interact; 2013 Oct; 205(3):188-97. PubMed ID: 23867903
[TBL] [Abstract][Full Text] [Related]
9. [Experimental study of extract from Prunella vulgaris inducing B, T lymphoma cell apoptosis].
Fu XR; Sun ZC; Zhang MZ
Zhong Yao Cai; 2012 Mar; 35(3):433-8. PubMed ID: 22876685
[TBL] [Abstract][Full Text] [Related]
10. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
11. The COX-2 inhibitor Celecoxib enhances the sensitivity of KB/VCR oral cancer cell lines to Vincristine by down-regulating P-glycoprotein expression and function.
Yan YX; Li WZ; Huang YQ; Liao WX
Prostaglandins Other Lipid Mediat; 2012 Jan; 97(1-2):29-35. PubMed ID: 21835258
[TBL] [Abstract][Full Text] [Related]
12. Importance of Bak for celecoxib-induced apoptosis.
Müller AC; Handrick R; Elsaesser SJ; Rudner J; Henke G; Ganswindt U; Belka C; Jendrossek V
Biochem Pharmacol; 2008 Oct; 76(9):1082-96. PubMed ID: 18778687
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of chemosensitivity measured by histoculture drug response assay to expression of multidrug resistance genes and proteins in gastric cancer].
Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Keshari RP; Zhang LY
Ai Zheng; 2009 Apr; 28(4):337-43. PubMed ID: 19622290
[TBL] [Abstract][Full Text] [Related]
14. HSP90 inhibitor enhances anti-proliferative and apoptotic effects of celecoxib on HT-29 colorectal cancer cells via increasing BAX/BCL-2 ratio.
Mohammadi A; Yaghoobi MM; GholamhoseynianNajar A; Kalantari-Khandani B; Sharifi H; Saravani M
Cell Mol Biol (Noisy-le-grand); 2016 Oct; 62(12):62-67. PubMed ID: 27894402
[TBL] [Abstract][Full Text] [Related]
15. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax.
Li X; Hong L; Zhao Y; Jin H; Fan R; Du R; Xia L; Luo G; Fan D
Biochem Cell Biol; 2007 Dec; 85(6):741-50. PubMed ID: 18059532
[TBL] [Abstract][Full Text] [Related]
16. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
[TBL] [Abstract][Full Text] [Related]
17. Preventing chemoresistance of human breast cancer cell line, MCF-7 with celecoxib.
Chen C; Shen HL; Yang J; Chen QY; Xu WL
J Cancer Res Clin Oncol; 2011 Jan; 137(1):9-17. PubMed ID: 20229271
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib upregulates multidrug resistance proteins in colon cancer: lack of synergy with standard chemotherapy.
Gradilone A; Pulcinelli FM; Lotti LV; Trifirò E; Martino S; Gandini O; Gianni W; Frati L; Aglianò AM; Gazzaniga P
Curr Cancer Drug Targets; 2008 Aug; 8(5):414-20. PubMed ID: 18690847
[TBL] [Abstract][Full Text] [Related]
19. Thymoquinone synergizes with arsenic and interferon alpha to target human T-cell leukemia/lymphoma.
Houssein M; Fatfat M; Habli Z; Ghazal N; Moodad S; Khalife H; Khalil M; Gali-Muhtasib H
Life Sci; 2020 Jun; 251():117639. PubMed ID: 32272181
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells.
Lin GL; Ting HJ; Tseng TC; Juang V; Lo YL
PLoS One; 2017; 12(10):e0185625. PubMed ID: 28968471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
